Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

newswise.com

1 of 0

Resource Description:

Use of certain medications known as monoclonal anti"“ tumor necrosis factor (TNF-) antibodies for the treatment of rheumatoid arthritis appears to be associated with an increased risk for herpes zoster (shingles), the painful infection characterized by blisters, according to a study in the February 18 issue of JAMA.

« Back to the Rheumatoid Arthritis Drug and Shingles WisdomCard

Related Health Centers:

Advertisement